Categories: News

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SUNNYVALE, Calif., Oct. 29, 2024 /PRNewswire/ — Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 7168007. A live and archived webcast of the event will be available in the “Investor Relations” section of the Ceribell website at https://investors.ceribell.com/

About Ceribell Inc.
Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is an AI-powered, rapidly deployable point-of-care electroencephalography (“EEG”) platform designed to address the unmet needs of patients in the acute care setting. The company is headquartered in Sunnyvale, Calif.

Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com

Media Contact
Corrie Rose
Press@ceribell.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html

SOURCE Ceribell, Inc.

Staff

Recent Posts

Insights From Digital Silk’s Recent Study Reveal Key Branding Priorities for U.S. Healthcare Providers

MIAMI, April 16, 2025 /PRNewswire/ -- Digital Silk, an award-winning agency focused on creating brand…

41 minutes ago

Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer

Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help…

41 minutes ago

Cloudforce Launches nebulaONE® on Microsoft Azure: The Leading AI Gateway for Higher Education

NATIONAL HARBOR, Md., April 16, 2025 /PRNewswire/ -- Cloudforce, a Maryland-based leader in cloud and…

41 minutes ago

Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US

 – Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and…

41 minutes ago

THINK Surgical Announces First Use of Maxx Orthopedics’ Freedom® Total Knee implant with the TMINI® Miniature Robotic System

FREMONT, Calif., April 16, 2025 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field…

41 minutes ago

Velatura Unveils Consent Manager+ with J&B Medical

First-of-its-kind AI-driven consent management platform empowers patients, clinicians, and administrators NEW YORK, April 16, 2025…

41 minutes ago